Forbes @Forbes
On Wednesday GOP presidential hopeful Vivek Ramaswamy sold 4 million shares in biotech firm Roivant Sciences at a price of $7.95 per share for a total of $32 million, netting him an estimated $24.2 million in after-tax proceeds. https://t.co/nMlkOvbvPD — PolitiTweet.org